Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,517 | 12,427 | 10,710 | 11 | 10,407 |
| Marketable Securities | 0 | N/A | N/A | N/A | 502 |
| Other current assets | 552 | 0 | 178 | 0 | 271 |
| TOTAL | $41,069 | $12,427 | $10,888 | $11 | $11,180 |
| Non-Current Assets | |||||
| PPE Net | 143 | 103 | 73 | N/A | 62 |
| Other Non-Current Assets | 10 | 0 | 0 | 0 | 9 |
| TOTAL | $153 | $103 | $73 | $N/A | $71 |
| Total Assets | $41,169 | $12,803 | $10,940 | $11 | $11,227 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5 | 0 | 0 | 0 | 134 |
| Accrued Expenses | 226 | N/A | N/A | N/A | 259 |
| Other current liabilities | 419 | N/A | N/A | N/A | 277 |
| TOTAL | $650 | $505 | $823 | $2 | $670 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $650 | $505 | $823 | $2 | $670 |
| Shareholders' Equity | |||||
| Common Shares | 91 | 76 | 72 | N/A | 68 |
| Retained earnings | -17,358 | N/A | N/A | N/A | -11,400 |
| Other shareholders' equity | 112 | 12,222 | 10,045 | 9 | 25 |
| TOTAL | $40,519 | $12,298 | $10,117 | $9 | $10,557 |
| Total Liabilities And Equity | $41,169 | $12,803 | $10,940 | $11 | $11,227 |